{{Rsnum
|rsid=6459409
|Gene=DTNBP1
|Chromosome=6
|position=15636622
|Orientation=plus
|GMAF=0.1703
|Gene_s=DTNBP1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 3.1 | 24.6 | 72.3
| HCB | 13.3 | 31.1 | 55.6
| JPT | 11.4 | 31.8 | 56.8
| YRI | 0.0 | 14.3 | 85.7
| ASW | 0.0 | 0.0 | 0.0
| CHB | 13.3 | 31.1 | 55.6
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23497497
|Title=Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes
|OA=1
}}{{PMID Auto
|PMID=17033966
|Title=Analysis of high-resolution HapMap of DTNBP1 (Dysbindin) suggests no consistency between reported common variant associations and schizophrenia.
|OA=1
}}